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Summary
Objectives: Administration of ﬁbroblast growth factor (FGF)-2 for 2 weeks induces a successful cartilaginous repair response in 5-mm full-
thickness articular cartilage defects in rabbits. The purpose of this study was to investigate the effects of a short time exposure to FGF-2 on the
repair of the defects.
Methods: Five-mm-diameter cylindrical defects, which do not repair spontaneously, were created in the femoral trochlea of the rabbit knees.
The defects were administered sterile saline or FGF-2 (150 pg/h) via an osmotic pump for the initial 1 day, 3 days, or 2 weeks, and we
assessed the FGF-2 action on the proliferation and migration of mesenchymal cells in the reparative tissue. Using a total of 126 rabbits, we
performed three sets of experiments. We also studied the effect of FGF-2 on migration of marrow-derived mesenchymal cells in vitro.
Results: FGF-2 treatment for 1 day or 3 days induced the sequential chondrogenic repair responses that led to successful cartilaginous
resurfacing of defects within 8 weeks as well as the 2-week treatment did. We conﬁrmed by a radioisotope study that FGF-2 injected was
rapidly eliminated from the defects (a residual ratio of 50% within 30 min). The effect of FGF-2 on cultured marrow-derived cells suggested that
FGF-2 facilitated the mobilization and migration of replicating mesenchymal cells from bone marrow.
Conclusions: Only 1 day exposure to FGF-2 is sufﬁcient for induction of the chondrogenic repair response in 5-mm-diameter full-thickness
defects of articular cartilage in rabbits. FGF-2 stimulated the recruitment of mesenchymal cells into the defects, which was a limiting step for
the induction of cartilage.
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Cartilage
Repair
SocietyIntroduction
Articular cartilage has a very limited capacity for repair.
Partial-thickness defects that are limited to the layer of
articular cartilage do not respond signiﬁcantly to any repair
process1,2. Full-thickness defects penetrating the subchon-
dral bone undergo repair processes that result in the
generation of either ﬁbrous or ﬁbrocartilaginous tissue or,
to a very limited extent, hyaline cartilage. Bone marrow
contains pluripotent mesenchymal progenitor cells, which
can differentiate into multiple differentiated cell-types such
as chondrocytes, osteocytes, adipocytes, and ﬁbroblasts3.
These marrow-derived mesenchymal cells have an essen-
tial role in the repair of the full-thickness defects of articular
cartilage4. The lineage progression of mesenchymal cells in
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defects4e6. In a mature rabbit model of small cylindrical
defects (%3 mm in diameter) created in the femoral trochlea,
marrow-derived mesenchymal cells spontaneously undergo
chondrogenic differentiation within 2 weeks after the creation
of the defects to regenerate surfacing articular cartilage
concomitantly with the repair of subchondral bone4. By
contrast, chondrogenesis does not occur in larger defects
(R5 mm in diameter), and the surface of the defects was
covered only with ﬁbrous tissue.
The analyses of skeletal development in embryos and
chondrogenic cell line in culture have shown that a variety
of signaling molecules are implicated as a critical regulatory
factor for a sequence of events during chondrogenesis7e10.
Based on these ﬁndings, attempts have been made to
promote the repair of full-thickness defects by the use of
such bioactive molecules11e13. Fibroblast growth factor-2
(FGF-2) is known to be a potent mitogen for a wide variety
of cell-types derived from mesoderm and neuro-ectoderm
in vitro14. Previous studies have also suggested that FGF
signaling participates in the support of the proliferation of
limb bud mesenchymal cells15,16. We previously demon-
strated the importance of FGF-2 released from surrounding
bone matrix to the defect cavities for the cartilaginous
repair: the local administration of neutralizing monoclonal4
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genic repair in the 3-mm-diameter small defects6. Admin-
istration of FGF-2 for 2 weeks in the 5-mm-diameter large
defects successfully stimulated accumulation of the pro-
liferating cell nuclear antigen (PCNA)-positive proliferating
mesenchymal cells to the same extent as in the 3-mm-
diameter smaller defects at 1e2 weeks after creation of
defects, and subsequently induced regeneration of articular
cartilage and the subchondral bone within 8 weeks17.
Several reports documented the effects of a short time
treatment to FGF-2 on chondrogenesis in vivo18,19. Shida
et al. demonstrated that single injection of FGF-2 into the
young rat knee joint promoted the expansion of chondro-
progenitor cell population in the femoral condylar ridge18. In
fracture-healing model, Kawaguchi et al. found a marked
increase in the cartilage formation in the callus at 1 week
after fracture, although more than 90% of FGF-2 disap-
peared from the injected site within 3 days19. Thus we
hypothesized that FGF-2 may act on the early stages of
chondrogenic repair process and enable the full-thickness
articular cartilage defects to initiate cartilaginous repair by
administration of the factor for a shorter period within 2
weeks. Here we investigated the effects of the exposure to
FGF-2 (150 ng/ml) for 1 day or 3 days on the repair
response of 5-mm-diameter full-thickness defects. Clear-
ance of FGF-2 administered into the defects was also
assessed by the radioisotope study. In addition, using
a radioisotope study, we assessed and examined the effect
of FGF-2 on migration of marrow-derived mesenchymal
cells in vitro.
Materials and methods
ANIMALS AND EXPERIMENTAL PROCEDURES
Adolescent (15e16 weeks) male Japanese white rab-
bits, weighing 3.0e3.4 kg, were used in this study. All
animals were housed individually, and animal care and
experimental procedures were conducted in accordance
with institutional guidelines (http://card.medic.kumamoto-u.
ac.jp/card/japanese/kisoku/kisoku.html). Forty-two rabbits
were anesthetized with intravenous administration of
sodium pentobarbital (30 mg/kg body weight). The right
knee joint was approached by means of a medial para-
patellar incision under sterile conditions. The patella was
dislocated laterally to expose the articular surface on the
femoral trochlea. Full-thickness cylindrical defects (5 mm in
diameter, 4 mm in depth) were created in the center of the
femoral trochlea with a hand drill equipped with a 5-mm-
diameter drill-bit, as described previously6.
After creation of the defects, the animals were ﬁtted with
an osmotic pump (Model 2002; Alzet, Palo Alto, CA, USA)
connected with silastic medical grade tubing (0.75 mm ID/
1.45 mm OD); a tubing about 5 mm long was introduced
into the articular capsule. The pump was placed sub-
cutaneously in the posterolateral region of the thigh.
Twenty-one rabbits were ﬁtted with an osmotic pump,
which had been previously ﬁlled with 200 ml of sterile
phosphate buffered saline (PBS) containing human re-
combinant FGF-2 (300 ng/ml; Takeda Chemical Industries,
Osaka, Japan). The pump has a normal pumping rate of
0.5 ml/h over a 2-week period. Another group of twenty-one
control animals received PBS alone with the same osmotic
pump system. The articular capsule and skin were closed
independently with 4-0 nylon sutures. All animals were
allowed to walk freely without any splintage.HISTOCHEMICAL ANALYSES
The animals treated with FGF-2 were randomly allocated
into three groups: administration for 1 day, 3 days, or 2
weeks (nZ 7 each). Control animals were also randomly
divided into three groups: administration of PBS for 1 day, 3
days, or 2 weeks (nZ 7 each). Depending on the
experimental protocols, the animals were re-anesthetized
on the ﬁnal day of FGF-2 administration, and the osmotic
pumps were removed without reopening the joint capsule.
In previous studies6,20, we conﬁrmed that a tip of the tubing
connected with an osmotic pump remains in the articular
cavity of the knee joint during the experiment.
All animals were sacriﬁced with an overdose of sodium
pentobarbital at 8 weeks after creation of the defects for the
subsequent histochemical analyses. This time point was
chosen to evaluate the repair of the defects, because the
previous study revealed that 3-mm-diameter defects, which
heal spontaneously, and 5-mm-diameter defects with FGF-
2 treatment for 2 weeks regenerated the epiphyseal
structure by 8 weeks6. The distal portion of each femur
was removed, and the harvested tissues were then ﬁxed in
4% paraformaldehyde at room temperature for 1 h, decal-
ciﬁed with 10% ethylenediamine tetraacetic acid (EDTA) for
3 weeks, and embedded in parafﬁn. Sections (5 mm thick)
were cut in the transverse plane, and stained with
hematoxylin and eosin or with safranin-O.
For semi-quantitative analysis of the reparative tissue,
the sections were examined in a blinded manner by two
observers not informed on the group assignment, and were
scored according to the histological grading scale of Pineda
et al., with some modiﬁcations (Table I)21. The scale used
here is inversely correlated to the original one so that better
recovery of articular structure has a higher score; the score
ranges from 0 (worst) to 14 (best)6. Three sets of experi-
ments were performed by using a total of 126 rabbits, and
reproducibly yielded similar results.
Table I
Scoring system for the histological appearance of full-thickness
defects of articular cartilagey
Characteristics Score
Filling of defects (%)
125 3
100 4
75 3
50 2
25 1
0 0
Reconstitution of osteochondral junction
Yes 2
Almost 1
Non-close 0
Matrix staining
Normal 4
Reduced staining 3
Signiﬁcant staining 2
Faint staining 1
No staining 0
Cell morphology
Normal 4
Mostly hyaline and ﬁbrocartilage 3
Mostly ﬁbrocartilage 2
Some ﬁbrocartilage, but mostly non-chondrocytic cells 1
Non-chondrocytic cell only 0
Perfect score 14
yModiﬁed from Pineda et al.21.
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THE REPARATIVE TISSUE
We assessed the proliferative capacity of the mesenchy-
mal cells that had migrated and ﬁlled the defects by
immunostaining the PCNA, in addition to the packing cell
density of the reparative tissues. Full-thickness defects
were created for 36 rabbits, which were ﬁtted with an
osmotic pump as described above. Eighteen animals
treated with FGF-2 were divided into three groups:
administration of FGF-2 for 1 day, 3 days, or 1 week
(nZ 6 each). Eighteen control animals treated with PBS
were also divided into three groups: administration of PBS
for 1 day, 3 days, or 1 week (nZ 6 each). Implanted
osmotic pumps were removed at the end of FGF-2
administration, as described above.
All animals were sacriﬁced at 1 week after creation of the
defects for the subsequent histological and immunohisto-
chemical analyses. The distal portion of each femur was
removed, and the harvest tissues were ﬁxed in 4%
paraformaldehyde for 1 h, decalciﬁed with 10% EDTA for
3 weeks, and embedded in parafﬁn. Sections (5 mm thick)
were cut in the transverse plane, and stained with
hematoxylin and eosin. For the immunostaining, the
sections were deparafﬁnized, and hydrated. Endogenous
peroxidase activity was blocked by 0.5% hydrogen peroxide
in methanol and washed in 0.1% bovine serum albumin
(BSA) in Tris-buffered saline (TBS). Nonspeciﬁc staining
was reduced by incubation with normal horse serum. The
sections were incubated with a monoclonal antibody
against PCNA (dilution 1:400; Dakopatts, Copenhagen,
Denmark) at room temperature for 1 h. Antibody binding
was visualized by using a Vectastain avidinebiotineperox-
idase complex (ABC) kit (Vector Laboratories, Burlingame,
CA) in combination with diaminobenzidine (DAB) solution
according to the manufacturer’s instructions. The sections
were then counterstained with methyl green. For the
detection of PCNA, the growth plate of Japanese white
rabbits was used as a positive control. Sections were
incubated with horse serum instead of speciﬁc primary
antibodies and stained as a negative control.
The packing cell density of the reparative tissue in the
defects was examined by the methods of Gallay et al.22
using the sections stained with hematoxylin and eosin. A
section of the defect was divided into 20 sampling square
areas (1 mm! 1 mm). We selected 15 areas other than the
ﬁve deeper peripheral ones where bone formation was
evident. Two ﬁelds were selected at a magniﬁcation of
!200 in each of sampling areas, and all nuclei except
those of endothelial cells in capillaries and inﬂammatory
cells were counted. To calculate the cell density in the
defect, the mean number of cell nuclei was divided by the
sampling area. Three sections from each parafﬁn block
were used to calculate the average cell density for one
animal. The mean and SD of thus obtained average cell
densities was calculated for ﬁve animals in each experi-
mental group.
The PCNA-positive cells in the reparative tissue were
counted according to the method of Aizawa et al.23 and
expressed by the percentage of the total number of cells in
the defect. Sampling square areas (1 mm! 1 mm) were
determined similarly as described above. Five ﬁelds were
selected randomly at a magniﬁcation of !400 in each
sampling area in the section. Because three sections from
each parafﬁn block were used, the positive and negative
undifferentiated cells were counted in a total of 225 ﬁelds for
one animal. The rate of occurrence of PCNA-positive cellsin each reparative tissue was expressed as the mean
number of positive cells divided by the total number of cells
for six animals in each experimental group. Sections were
examined in a blinded manner by two evaluators not
informed on the group assignment. Two sets of experiments
were performed by using a total of 72 rabbits, and yielded
similar results.
ASSESSMENT OF CLEARANCE OF FGF-2 ADMINISTERED INTO
FULL-THICKNESS DEFECTS
Clearance of FGF-2 administered into the full-thickness
articular cartilage defects was monitored using a radioiso-
tope study12,24,25. 125I-labeled FGF-2 was purchased from
NEN Life Science Products, Inc. (Boston, MA, USA), and
the speciﬁc activity was 88.4 mCi/mg. For 12 rabbits, 5-mm-
diameter full-thickness articular cartilage defects were
created as above. The capsule and skin were repaired with
4-0 nylon sutures independently. On the day following the
creation of the defects, three rabbits were re-anesthetized
to expose the defect of the right knee again, and a total of
5 ng of 125I-labeled FGF-2 suspended in 5 ml of PBS, whose
radioactivity was estimated to be 0.343 mCi, was injected
into the blood clot ﬁlling the defect. After 30, 60, or 90 min,
one rabbit at a time was sacriﬁced, and blood clots were
immediately collected by wiping off with the cotton. The
radioactivity included in the cotton was counted with an
automatic gamma counter (ARC-380; Aloka, Tokyo, Ja-
pan). Just after sacriﬁcing the animals, the same amount of
125I-labeled FGF-2 was injected into the blood clot ﬁlling the
defect of the left knee, and radioactivity in the clot was
counted immediately in the same manner. All measure-
ments of radioactivity were completed within 2 min after
wiping off the blood clots with the cotton. In the preliminary
experiments, we injected the same amount of 125I-labeled
FGF-2 into the cotton and the blood clot ﬁlling the defect,
and the blood clots were immediately collected by wiping off
with the cotton. The comparison of the radioactivity included
in each cotton demonstrated that the recovery of the
radioactivity was 91.3G 4.8%. The residual radioactivity in
each animal was calculated from the ratio of radioactivity in
the clot of the right knee divided by that of the left knee.
Four sets of experiments were performed by using a total of
12 rabbits within a day. The residual radioactivity in each
time point was expressed as the meanGSD for four
animals in each experimental group.
MIGRATORYRESPONSEOFMARROW-DERIVEDMESENCHYMAL
CELLS TO FGF-2
The effect of FGF-2 on migration of marrow-derived
mesenchymal cells was assessed in vitro. Rabbit marrow-
derived mesenchymal cell cultures were established using
modiﬁed previously described methods26,27. A rabbit was
sacriﬁced with an overdose of sodium pentobarbital, and
tibias and femurs were excised aseptically. Their proximal
and distal ends were cut off, and the marrow from the
femoral and tibial midshafts was ﬂushed out into serum-free
Ham’s F-12 medium (Bioﬂuids Biosource International,
Rockville, MD, USA). A single cell suspension was pre-
pared by sequentially drawing the marrow sample into
a syringe three times through needles of decreasing size
( gauge 18, 21, 23). The dissociated cells were washed
twice with PBS, pelleted by centrifugation for 5 min, and
then resuspended in Ham’s F-12 medium containing 10%
fetal bovine serum (FBS; Cosmo Bio Co., Ltd., Tokyo,
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100 mg/ml; Celox Co., Hopkins, MN, USA). The bone
marrow cells were seeded at 5.0! 106 nucleated cells/ml
in a 90-mm plastic dish and cultured at 37(C in a humidiﬁed
atmosphere of 5% CO2. After 5 days, non-adherent cells
were washed off. From this time onward the medium was
changed every other day. When cells had grown to
conﬂuence, they were harvested by trypsinization, collected
by centrifugation, suspended in serum-free Ham’s F-12
medium containing 0.1% BSA, and used for subsequent
experiments.Migratory response of marrow-derived mesenchymal
cells to a gradient of FGF-2 was measured in multiwell
chemotaxis chambers with polycarbonate nucleopore ﬁlters
of 8 mm pore size (Kurabo Industries Ltd., Osaka, Japan)
using a modiﬁed checkerboard format. FGF-2 was added at
a concentration of 0e50 ng/ml in serum-free Ham’s F-12
medium containing 0.1% BSA to the bottom well of the
chamber. The upper chamber was then placed on the plate,
and a suspension of marrow-derived mesenchymal cells in
serum-free Ham’s F-12 medium containing 0.1% BSA
supplemented with the concentration of 0e10 ng/ml ofFig. 1. Regeneration of 5-mm full-thickness defects treated with PBS alone for 1 day (A), 3 days (B) or 2 weeks (C), or with FGF-2 (150 pg/h)
for 1 day (D), 3 days (E), or 2 weeks (F). Panel G is higher-power photomicrograph of the framed area in panel D. All sections were stained
with safranin-O. Bar, 1 mm for AeF; 100 mm for G.
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After incubation of the chamber for 5 h at 37(C in 5% CO2,
the upper surface of the ﬁlter of each well was rubbed with
a cotton swab to remove the cells which had attached but
not migrated. The ﬁlter was ﬁxed in 100% methanol for
5 min, stained with Giemsa, and then mounted upside down
on glass slides. For each well, the number of migrated cells
was counted in 16 randomly selected ﬁelds under light
microscopy at a magniﬁcation of !400. Seven sets of
experiments were performed independently by using seven
rabbits, and the data were expressed as the meanGSD in
each experiment.
STATISTICAL ANALYSES
Statistical analyses on the histological score, the rate of
occurrence of PCNA-positive cells, and data of migratory
response were performed using KruskaleWallis test and
ManneWhitney’s U-test. A P value of less than 0.05 was
considered signiﬁcant.
Results
EFFECT OF FGF-2 ON REPAIR RESPONSE
The histological appearance of the reparative tissues at
8 weeks after creation of 5-mm-diameter full-thickness
defects is shown in Fig. 1. In the control groups treated with
PBS alone, the defects were covered only with ﬁbrous
tissue, although the subchondral bone was almost fully
reconstituted. The cells surfacing the defects were mostly
non-chondrocytic and the matrix was not stained by
safranin-O. By contrast, in the FGF-2-treated groups, well-
developed cartilage stained by safranin-O covered the
defects with the reconstruction level of the subchondral
bone up to the original boneearticular cartilage junction,
regardless of whether FGF-2 was administered for 1 day, 3
days, or 2 weeks. Spherical-shaped chondrocytes were
arranged in vertical columnar distribution in the repair
cartilage layer of the defects. Figure 2 shows the semi-
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Fig. 2. Histological score for the regeneration of full-thickness
defect at 8 weeks after creation of the defects according to the
histological grading scale (Table I). The defects were treated with
PBS alone or FGF-2 (150 pg/h) for 1 day, 3 days or 2 weeks.
Values are meansG SD (nZ 7). Asterisks indicate results that
were signiﬁcantly different between the two groups (Manne
Whitney’s U-test; P! 0.05).quantitative histological evaluation of the reparative tissues
in each group according to the grading scale of Pineda et al.
with some modiﬁcations21. The scores of FGF-2-treated
groups were signiﬁcantly higher than those of control
groups. Interestingly, the FGF-2 administration for 1 day
or 3 days induced a remarkable chondrogenic repair
response to the same extent as the administration for 2
weeks6 (Fig. 2). The results indicate that the 1 day exposure
to FGF-2 was sufﬁcient for the induction of a regenerative
repair response in large defects.
EXPRESSION OF PCNA IN THE REPARATIVE TISSUE
We assessed the proliferative capacity of the mesenchy-
mal cells in the reparative tissues at 1 week after creation of
the defects by immunostaining using the PCNA. We ﬁrst
stained the sections of the reparative tissues with hema-
toxylin and eosin. Then, semi-serial sections were stained
with PCNA antibody, and examined at high magniﬁcation
(Fig. 3). The histological appearance of the reparative
tissues at 1 week in the FGF-2-treated defects was not
signiﬁcantly different from that of the control defects treated
with PBS alone, regardless of the duration of FGF-2
administration. Undifferentiated spindle-shaped mesenchy-
mal cells proliferated at the periphery of the defect, and the
center of the defects was ﬁlled with blood clots. Osteoblas-
tic differentiation took place near the surface of subchondral
bone in the depth and edge of the defects (Fig. 3).
In the control defects, immunoreactivity to PCNA was
barely detectable in mesenchymal cells in the reparative
tissue, except in the marginal area [Fig. 3(DeF)]. By
contrast, most of the undifferentiated cells were positively
stained with PCNA antibody in the FGF-2-treated defects
[Fig. 3(JeL)]28. There was no signiﬁcant difference in the
PCNA immunoreactivity among the groups treated with
FGF-2. Table II summarizes the packing cell density and
the rate of occurrence of PCNA-positive cells in the
reparative tissues. The rate of occurrence of PCNA-positive
cells was signiﬁcantly higher in all FGF-2-treated defects
(50% or more) than those of control defects at 1 week after
creation of the defects28. The packing cell density at 1 week
was also signiﬁcantly higher in all FGF-2-treated defects
than that in the control defects. No signiﬁcant difference
was seen in the packing cell density among the groups
treated with FGF-2.
CLEARANCE OF 125I-FGF-2 FROM THE DEFECTS
Clearance of FGF-2 administered in the defects was
assessed using a radioisotope study using 125I-labeled
FGF-224, as described in Materials and Methods section.
The residual radioactivity in each time point is shown in
Fig. 4. It rapidly decreased in a time-dependent manner.
Radioactivity found 30 min after injection into the defect was
approximately 40% of total, and only 20% of total activity
remaining at 90 min after injection.
MIGRATORY RESPONSE OF MARROW-DERIVED MESENCHY-
MAL CELLS TO FGF-2
The migratory responses of rabbit marrow-derived mes-
enchymal cells to FGF-2 are shown in Fig. 5. Chemotactic
migration was signiﬁcantly stimulated by FGF-2 in a concen-
tration-dependent manner from 0.1 ng/ml to 10 ng/ml.
Maximum response was observed at 10 ng/ml of FGF-2,
where migrated cell number was 9.6-fold higher than that in
the absence of FGF-2. At a concentration of 50 ng/ml of
839Osteoarthritis and Cartilage Vol. 12, No. 10Fig. 3. Transverse sections of the reparative 5-mm-diameter defects treated with PBS alone for 1 day (A and D), 3 days, (B and E) or 1 week
(C and F), and treated with FGF-2 (150 pg/h) for 1 day (G and J), 3 days, (H and K) or 1 week (I and L). All animals were killed at 1 week after
creation of the defects. Hematoxylin and eosin staining (AeC, GeI) and PCNA immunostaining (DeF, JeL) were carried out. Panels D, E, F, J,
K and L represent the PCNA-positive cells in the areas denoted by the framed areas in panels A, B, C, G, H and I, respectively, at a higher
magniﬁcation. The sections were counterstained with methyl green. Bar, 1 mm for AeC and GeI; 125 mm for DeF and JeL.FGF-2, there was a decline in the migratory response,
although a signiﬁcant stimulation of chemotactic migration
was still evident. We then performed a checkerboard
analysis to distinguish chemotactic migration observed in
response to a positive concentration gradient of FGF-2 from
the random migration observed in response to FGF-2
(chemokinetic migration). As shown in Table III, the
chemotactic action of FGF-2 was evident, but only minimum
or no chemokinetic migration was observed.
Discussion
We previously reported that administration of FGF-2 for
initial 2 weeks in the 5-mm-diameter full-thickness defects
of articular cartilage, which is large enough not to repair
spontaneously, resulted in the successful regeneration of
articular cartilage and the subchondral bone within 8weeks6. In the present study, we investigated the effects
of the short time exposure to FGF-2 ( for 1 day or 3 days) on
the repair of the 5-mm-diameter defects. The results
indicated that a short-term administration of FGF-2 was
sufﬁcient for the induction of a regenerative repair response
in large defects. The FGF-2 administration for 1 day yielded
the regenerative repair response in large defects to the
same degree as the administration for 2 weeks.
In the repair of full-thickness articular cartilage defects,
undifferentiated cells migrating from the underlying bone
marrow into the defect cavities are thought to be a primary
source of repair cells4, although synovium has been
suggested as the other progenitor pool in several stud-
ies2,29,30. In previous studies6,17,20, we have shown
a sequential reparative response after creation of full-
thickness defects: the defect cavities are ﬁrst ﬁlled with
blood clots. Undifferentiated cells appear at the periphery of
blood clots at 2e3 days after creation of defects, and then
840 H. Chuma et al.: Short-term exposure to FGF-2 on cartilage repairthey migrate toward the center of the clot. By 1 week, the
defect cavities are mostly ﬁlled with the mesenchymal
cells28. With immunohistochemical analysis using CD68,
CD31 and alkaline phosphatase to assess the presence of
macrophages, vascular endothelial cells, and osteoblasts,
we detected no positive staining of these antigens in the
reparative tissue of the defect cavities28. These indicated
that the reparative tissue is primarily composed of un-
differentiated ﬁbroblastic cells.
Active expansion and maintenance of progenitor cell
populations is thought to be an important prerequisite for
initiation of chondrogenesis13,31e33. We previously demon-
strated that the capacity of reparative tissue to form car-
tilage in full-thickness articular cartilage defects was well
correlated with the occurrence in the defects of PCNA-
positive undifferentiated cell populations17: the rate of
occurrence of PCNA-positive cells in the reparative tissue
at 1 week was about 60% in 3-mm-diameter defects which
are small enough to regenerate articular cartilage sponta-
neously, while it was signiﬁcantly lower in the 5-mm-
diameter defects (about 15%)17. Supplementation of FGF-2
for 1 week increased the rate of PCNA-positive cells in the
5-mm-diameter defects to the level of the 3-mm-diameter
Table II
Cell density and occurrence of the PCNA-positive undifferentiated
cells in the reparative tissue at 1 week after creation of defects
Treatment
period
Cell density
(cells! 103/mm)
PCNA-positive cells
(% of total)
FGF-2 PBS alone FGF-2 PBS alone
1 day 1.22G 0.31 0.74G 0.19 51.9G 14.4 28.9G 8.7
3 days 1.12G 0.16 0.69G 0.20 54.1G 7.0 27.3G 5.6
1 week 1.21G 0.16 0.78G 0.24 53.9G 6.1 32.9G 4.3
Values are meansGSD for six animals.
All the nuclei were counted in a total of 90 ﬁelds using three
sections for each animal at a magniﬁcation of !200, as described
in Materials and Methods.
PCNA-positive and negative undifferentiated cells were also
counted in a total of 225 ﬁelds using three sections for each animal
at a magniﬁcation of !400.
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Fig. 4. Time course of the 125I-labeled FGF-2 clearance ratio.
Values are meanG SD (nZ 4).defects. The present study revealed that the rate of
occurrence of PCNA-positive cells was as high in the
5-mm-diameter defects treated with FGF-2 only for 1 day as
in the defects treated with FGF-2 for 1 week. PCNA is
a 36 kDa acidic nuclear protein which is essential for DNA
synthesis34e36. This protein is synthesized from the late G1
phase to the S phase of the cell cycle35,37, which means
that not all proliferating cells are stained by PCNA
antibodies. The rate of occurrence of PCNA-positive cells
is smaller than actual proportion of the proliferative
component. Although the proportion of the duration of each
phase in the cell cycle varies among the cell-types38e40,
high ratio of occurrence of PCNA-positive cells of greater
than 50% in the defects treated with FGF-2 for 1 day may
indicate that almost all repair cells in the defect cavities are
in a proliferative state.
Several investigators reported the rapid clearance of
FGFs from the applied sites in vivo19,24. FGF-2 injected into
adult mouse knee joints remained for only several hours
after injection18. In agreement, when FGF-2 was injected
into the blood clot ﬁlling the defect in our model, more than
half of FGF-2 injected was cleared from the defect cavity
within 30 min (Fig. 4). The half-life of PCNA is reported to be
8e60 h depending on the type of cells41. Therefore, when
the rapid clearance of FGF-2 is taken into consideration, it is
unlikely that FGF-2 treatment for 1 day directly promotes
a high proliferative activity of the marrow-derived mesen-
chymal cells, as indexed by a high rate of occurrence
of PCNA-positive cells. The critical limiting step for the
induction of cartilaginous repair is speculated to be migra-
tion and recruitment of marrow-derived mesenchymal cells
into defect cavities, which is one of the earliest cellular
events in the repair of full-thickness articular cartilage
defects. In addition to the mitogenic effects, FGF-2 is known
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Fig. 5. Chemotactic response of marrow-derived mesenchymal
cells to FGF-2. Marrow-derived mesenchymal cells placed in
the upper well of the chamber after loading the lower well with
FGF-2 at 0.1e50 ng/ml and FGF-free medium (0 ng/ml) as
a negative control. Values are meanGSD for seven experiments.
*Signiﬁcantly different from 0 ng/ml, **signiﬁcantly different from
0.1 ng/ml, and ***signiﬁcantly different from 1 ng/ml (Manne
Whitney’s U-test; P! 0.05).
841Osteoarthritis and Cartilage Vol. 12, No. 10to stimulate migration of different cell-types, including
keratocytes, vascular endothelial cells, neural crest cells,
and embryonic limb bud cells 42e45. However, only limited
information is available regarding the migratory effects of
FGF-2 on marrow-derived mesenchymal cell. Therefore, we
examined the effect of FGF-2 on the migration of rabbit
marrow-derived mesenchymal cells (Table III and Fig. 5).
Isolation and cultures of marrow-derived mesenchymal
cells were carried out using minor modiﬁcations of the
reported methods26,27. The osteochondrogenic potential of
these cells was conﬁrmed by diffusion chamber assay in
nude mice26. The in vitro migration assay showed that FGF-
2 stimulated the directional chemotactic migration of
marrow-derived mesenchymal cells in a concentration-
dependent manner, producing a peak response at
10 ng/ml. Thus the present in vitro results support our
in vivo observations that mobilization and recruitment of
mesenchymal cells is the primary site of FGF-2 action.
In the present study, we demonstrated that the FGF-2
administration for 1 day yielded the successful chondrogenic
repair response to the same extent as the administration for
3 days or 2 weeks. Histological analysis revealed that FGF-2
administration for 1 day was sufﬁcient to regenerate the
epiphyseal structure, including resurfacing articular cartilage
and the subchondral bone up to the original bone-articular
junction. Previous immunohistochemical studies using
speciﬁc antibodies against type II collagen and glycosami-
noglycans indicated that regenerated tissue contains
abundant cartilaginous matrix components in 5-mm-diame-
ter defect with FGF-2 treatment for 2 weeks28. Further
investigations are needed to clarify whether the duration of
FGF-2 administration may affect the mechanical properties
of the regenerated cartilage or not.
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